And the inhibitory effect of KAI was observed only in the presence of KIF13B in EC (Fig 5), suggesting the main target of KAI is KIF13B-mediated VEGFR2 trafficking in EC, not survival of cancer cells in the bloodstream nor colonizing of cancer cells in the lungs. The gene discussed is KIF13B; the disease is cancer.